UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 308

Sortiert nach

Larger Vancomycin Doses (at Least Four Grams per Day) Are Associated with an Increased Incidence of Nephrotoxicity

Antimicrobial Agents and Chemotherapy, 2008-04, Vol.52 (4), p.1330-1336

2008

Volltextzugriff (PDF)

Suppression of Emergence of Resistance in Pathogenic Bacteria: Keeping Our Powder Dry, Part 1

Antimicrobial agents and chemotherapy, 2016-03, Vol.60 (3), p.1183-1193

2016

Volltextzugriff (PDF)

Optimization of Aminoglycoside Therapy

Antimicrobial Agents and Chemotherapy, 2011-06, Vol.55 (6), p.2528-2531

2011

Volltextzugriff (PDF)

Suppression of Emergence of Resistance in Pathogenic Bacteria: Keeping Our Powder Dry, Part 2

Antimicrobial agents and chemotherapy, 2016-03, Vol.60 (3), p.1194-1201

2016

Volltextzugriff (PDF)

Pharmacokinetics and Pharmacodynamics of Antimicrobials

Clinical infectious diseases, 2007-07, Vol.45 (Supplement-1), p.S89-S95

DRUSANO, G. L

2007

Volltextzugriff (PDF)

Prevention of Resistance: A Goal for Dose Selection for Antimicrobial Agents

Clinical infectious diseases, 2003-01, Vol.36 (Supplement-1), p.S42-S50

Drusano, G L

2003

Volltextzugriff (PDF)

Piperacillin-Tazobactam for Pseudomonas aeruginosa Infection: Clinical Implications of an Extended-Infusion Dosing Strategy

Clinical infectious diseases, 2007-02, Vol.44 (3), p.357-363

2007

Volltextzugriff (PDF)

Impact of Granulocytes on the Antimicrobial Effect of Tedizolid in a Mouse Thigh Infection Model

Antimicrobial Agents and Chemotherapy, 2011-11, Vol.55 (11), p.5300-5305

2011

Volltextzugriff (PDF)

In Vivo Pharmacodynamics of Torezolid Phosphate (TR-701), a New Oxazolidinone Antibiotic, against Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus Strains in a Mouse Thigh Infection Model

Antimicrobial Agents and Chemotherapy, 2011-07, Vol.55 (7), p.3453-3460

2011

Volltextzugriff (PDF)

Determination of the Dynamically Linked Indices of Fosfomycin for Pseudomonas aeruginosa in the Hollow Fiber Infection Model

Antimicrobial agents and chemotherapy, 2018-06, Vol.62 (6)

2018

Volltextzugriff (PDF)

Polymyxin B Pharmacodynamics in the Hollow-Fiber Infection Model: What You See May Not Be What You Get

Antimicrobial agents and chemotherapy, 2021-07, Vol.65 (8), p.e0185320-e0185320

2021

Volltextzugriff (PDF)

The Combination of Fosfomycin plus Meropenem Is Synergistic for Pseudomonas aeruginosa PAO1 in a Hollow-Fiber Infection Model

Antimicrobial agents and chemotherapy, 2018-12, Vol.62 (12)

2018

Volltextzugriff (PDF)

Impact of Meropenem in Combination with Tobramycin in a Murine Model of Pseudomonas aeruginosa Pneumonia

Antimicrobial Agents and Chemotherapy, 2013-06, Vol.57 (6), p.2788-2792

2013

Volltextzugriff (PDF)

Building Optimal Three-Drug Combination Chemotherapy Regimens

Antimicrobial agents and chemotherapy, 2020-10, Vol.64 (11)

2020

Volltextzugriff (PDF)

Penetration of Meropenem into Epithelial Lining Fluid of Patients with Ventilator-Associated Pneumonia

Antimicrobial Agents and Chemotherapy, 2011-04, Vol.55 (4), p.1606-1610

2011

Volltextzugriff (PDF)

Dose Fractionation of Moxifloxacin for Treatment of Tuberculosis: Impact of Dosing Interval and Elimination Half-Life on Microbial Kill and Resistance Suppression

Antimicrobial agents and chemotherapy, 2021-03, Vol.65 (4)

2021

Volltextzugriff (PDF)

Back to the Future: Using Aminoglycosides Again and How to Dose Them Optimally

Clinical infectious diseases, 2007-09, Vol.45 (6), p.753-760

2007

Volltextzugriff (PDF)

Pharmacodynamics of Ceftazidime plus Avibactam against KPC-2-Bearing Isolates of Klebsiella pneumoniae in a Hollow Fiber Infection Model

Antimicrobial agents and chemotherapy, 2019-08, Vol.63 (8)

2019

Volltextzugriff (PDF)

Linezolid Kills Acid-Phase and Nonreplicative-Persister-Phase Mycobacterium tuberculosis in a Hollow-Fiber Infection Model

Antimicrobial agents and chemotherapy, 2018-08, Vol.62 (8)

2018

Volltextzugriff (PDF)

Pharmacodynamics of fosfomycin: insights into clinical use for antimicrobial resistance

Antimicrobial agents and chemotherapy, 2015-09, Vol.59 (9), p.5602-5610

2015

Volltextzugriff (PDF)

Pharmacodynamics of β-Lactamase Inhibition by NXL104 in Combination with Ceftaroline: Examining Organisms with Multiple Types of β-Lactamases

Antimicrobial Agents and Chemotherapy, 2012-01, Vol.56 (1), p.258-270

2012

Volltextzugriff (PDF)

The Funnel: a Screening Technique for Identifying Optimal Two-Drug Combination Chemotherapy Regimens

Antimicrobial agents and chemotherapy, 2021-01, Vol.65 (2)

2021

Volltextzugriff (PDF)

Impact of Burden on Granulocyte Clearance of Bacteria in a Mouse Thigh Infection Model

Antimicrobial Agents and Chemotherapy, 2010-10, Vol.54 (10), p.4368-4372

2010

Volltextzugriff (PDF)

Population Pharmacokinetics of Extended-Infusion Piperacillin-Tazobactam in Hospitalized Patients with Nosocomial Infections

Antimicrobial Agents and Chemotherapy, 2012-08, Vol.56 (8), p.4087-4094

2012

Volltextzugriff (PDF)

Activity of Moxifloxacin against Mycobacterium tuberculosis in Acid Phase and Nonreplicative-Persister Phenotype Phase in a Hollow-Fiber Infection Model

Antimicrobial agents and chemotherapy, 2018-12, Vol.62 (12)

2018

Volltextzugriff (PDF)

1 – 25 von 308

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(299)
Mit Volltextzugriff
(274)

Publikationsform

Sprache

Englisch
(308)
Japanisch
(36)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(244)
Science & Technology
(244)
Humans
(211)
Microbiology
(195)
Biological And Medical Sciences
(183)
Medical Sciences
(181)
Pharmacology & Pharmacy
(164)
Pharmacology. Drug Treatments
(156)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(145)
Male
(92)
Microbial Sensitivity Tests
(91)
Female
(84)
Infectious Diseases
(84)
Adult
(80)
Antibacterial Agents
(67)
Animals
(55)
Middle Aged
(54)
Anti-Bacterial Agents - Pharmacokinetics
(50)
Pharmacology
(49)
Models, Biological
(48)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Larger Vancomycin Doses (at Least Four Grams per Day) Are Associated with an Increased Incidence of Nephrotoxicity

Suppression of Emergence of Resistance in Pathogenic Bacteria: Keeping Our Powder Dry, Part 1

Optimization of Aminoglycoside Therapy

Suppression of Emergence of Resistance in Pathogenic Bacteria: Keeping Our Powder Dry, Part 2

Pharmacokinetics and Pharmacodynamics of Antimicrobials

Prevention of Resistance: A Goal for Dose Selection for Antimicrobial Agents

Piperacillin-Tazobactam for Pseudomonas aeruginosa Infection: Clinical Implications of an Extended-Infusion Dosing Strategy

Impact of Granulocytes on the Antimicrobial Effect of Tedizolid in a Mouse Thigh Infection Model

In Vivo Pharmacodynamics of Torezolid Phosphate (TR-701), a New Oxazolidinone Antibiotic, against Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus Strains in a Mouse Thigh Infection Model

Determination of the Dynamically Linked Indices of Fosfomycin for Pseudomonas aeruginosa in the Hollow Fiber Infection Model

Polymyxin B Pharmacodynamics in the Hollow-Fiber Infection Model: What You See May Not Be What You Get

The Combination of Fosfomycin plus Meropenem Is Synergistic for Pseudomonas aeruginosa PAO1 in a Hollow-Fiber Infection Model

Impact of Meropenem in Combination with Tobramycin in a Murine Model of Pseudomonas aeruginosa Pneumonia

Building Optimal Three-Drug Combination Chemotherapy Regimens

Penetration of Meropenem into Epithelial Lining Fluid of Patients with Ventilator-Associated Pneumonia

Dose Fractionation of Moxifloxacin for Treatment of Tuberculosis: Impact of Dosing Interval and Elimination Half-Life on Microbial Kill and Resistance Suppression

Back to the Future: Using Aminoglycosides Again and How to Dose Them Optimally

Pharmacodynamics of Ceftazidime plus Avibactam against KPC-2-Bearing Isolates of Klebsiella pneumoniae in a Hollow Fiber Infection Model

Linezolid Kills Acid-Phase and Nonreplicative-Persister-Phase Mycobacterium tuberculosis in a Hollow-Fiber Infection Model

Pharmacodynamics of fosfomycin: insights into clinical use for antimicrobial resistance

Pharmacodynamics of β-Lactamase Inhibition by NXL104 in Combination with Ceftaroline: Examining Organisms with Multiple Types of β-Lactamases

The Funnel: a Screening Technique for Identifying Optimal Two-Drug Combination Chemotherapy Regimens

Impact of Burden on Granulocyte Clearance of Bacteria in a Mouse Thigh Infection Model

Population Pharmacokinetics of Extended-Infusion Piperacillin-Tazobactam in Hospitalized Patients with Nosocomial Infections

Activity of Moxifloxacin against Mycobacterium tuberculosis in Acid Phase and Nonreplicative-Persister Phenotype Phase in a Hollow-Fiber Infection Model

Suchergebnisse filtern